Characteristics and Treatment Trends of Young Breast Cancer in China

Sponsor
Chinese Academy of Medical Sciences (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05068115
Collaborator
(none)
1,000
35

Study Details

Study Description

Brief Summary

To describe the clinical characteristics, the diagnosis and treatment, the survival status and change trend of young breast cancer patients in China from 2000 to 2015, and to explore and discuss the main influencing factors.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Clinical characteristics, diagnosis and treatment, survival status

Detailed Description

In this study, medical records and follow-up information of young breast cancer patients (age ≤35 years at first diagnosis) who were first diagnosed and treated in the years (2000, 2003, 2006, 2009, 2012 and 2015) were collected from multiple hospitals in China from 2000 to 2015, to establish a retrospective cohort of young breast cancer patients. Clinical characteristics, diagnosis and treatment, and survival rates of young breast cancer patients from 2000 to 2015 were analyzed. To explore the main factors affecting the clinical diagnosis and treatment and the survival of patients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
An Study on the Trend of Change and Influencing Factors of Clinicopathologic Characteristics, Diagnosis and Treatment Pattern, and Survival Status of Young Breast Cancer in China
Anticipated Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
1

Young breast cancer patients in China from 2000 to 2015, of whom the clinical features, diagnosis and treatment models and survival status are described.

Procedure: Clinical characteristics, diagnosis and treatment, survival status
Describe the clinical characteristics, diagnosis and treatment, survival status and the trends of young breast cancer
Other Names:
  • This is a retrospective study to observe and describe the diagnosis and treatment of previous young breast cancer patients without intervention
  • Outcome Measures

    Primary Outcome Measures

    1. Clinical features and trend [Between 2000 and 2015]

      To describe the clinical characteristics and trends of young breast cancer patients in China

    2. Diagnosis and treatment and trend [Between 2000 and 2015]

      To describe the methods of diagnosis and treatment in young breast cancer patients in China and the changing trend, to explore the main factors affecting diagnosis and treatment

    3. Survival situation and change trend [Between 2000 and 2015]

      To describe the survival and change trend of young breast cancer patients in China, to explore the main factors affecting the prognosis of young breast cancer patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Young Breast cancer patients (≤35 years old) in China
    Exclusion Criteria:
    • Breast cancer patients (>35 years old) in China

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Chinese Academy of Medical Sciences

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Peng Yuan, Professor, Chinese Academy of Medical Sciences
    ClinicalTrials.gov Identifier:
    NCT05068115
    Other Study ID Numbers:
    • NCC2985
    First Posted:
    Oct 5, 2021
    Last Update Posted:
    Oct 13, 2021
    Last Verified:
    Oct 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 13, 2021